Lumasonix is a pioneering brand in the field of cancer diagnosis and treatment. They have developed the Lumasonix Blood Cell Analyzer, an innovative and sophisticated system that detects and analyzes cancer tumor cells in the blood stream. By identifying circulating tumor cells (CTCs), which appear even before the primary tumor becomes detectable, this cutting-edge technology enables early detection and accurate evaluation of prognosis.

The analyzer works without the need for fluorescent reagents or specific biomarkers, using light and ultrasound to rapidly identify, count, size, and determine the morphology and internal structure of individual cells. It offers a non-destructive and label-free approach, providing detailed profiles of each cell in the sample. This technology has already proven its feasibility through successful characterization of breast cancer, colorectal cancer, melanoma, and other biological cells.

Through their groundbreaking work, Lumasonix is revolutionizing cancer diagnosis and treatment, providing a valuable tool for monitoring treatment efficacy and disease progression